Mark Goodman
Managing Director @ MassMutual Ventures
Boston, United States
Mark Goodman is a Series A investor at MassMutual Ventures in Boston focused on Information Technology and Software. Mark Goodman is Managing Director at MassMutual Ventures. Attended Northwestern University - Kellogg School of Management.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries Mark Goodman invests in
Stages Mark Goodman invests in
Countries Mark Goodman invests in
Investment Focus
Industry
- Information Technology 4 (44%)
- Software 3 (33%)
- Cyber Security 3 (33%)
- Network Security 2 (22%)
- SaaS 1 (11%)
Stage
- Series A 4 (44%)
- Series B 3 (33%)
- Seed 1 (11%)
- Series C 1 (11%)
Country
- United States 5 (56%)
- Israel 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
AI fighting AI.CISOs face an impossible risk landscape today. 80% of cybersecurity breaches start because of employee error. The problem is exacerbating with generative AI, as a single hacker can specifically target thousands of employees in the same amount of time that they used to specifically target tens of employees with social engineering.CISOs lack tools to deal with employee risk and are held accountable when a breach inevitably happens.By leveraging AI at each step, Dune Security empowers organizations to quantify individual risk through analyzing user behavior, context, learning patterns, and third party data. This allows the automation of tailored cybersecurity measures to each individual, transforming vulnerabilities into strengths. Dune is the central engine of all employee risk data, which is a solution that is not just timely for organizations but necessary in navigating the present cybersecurity landscape. This gives the CISO the capability to understand who are the high risk employees, to what extent, and why - as well as automatically remediate and restrict access to keep their organization safe.Today, Dune Security uniquely replaces legacy and ineffective security awareness training by pinpointing the crucial 8% of employees responsible for 80% of the risk, ensuring all employees receive personalized, machine learning-driven training tailored to their risk profile. CISOs also have easy access to quantifiable data via robust reporting and API-out capability, enabling them to both report to compliance auditors, regulators, and insurance underwriters, as well as restrict access to high-risk employees through other security systems. | $6M / Seed / Jan 29, 2025 | |
|
|
SecZetta provides their customers with consulting and software development services that focus on identity and access management. Its implementation services focus on privileged account management. Its consulting services focus on governance and risk management frameworks, and security audit.SecZetta offers NE Profile, a software solution thatenables businesses to manage nonemployees and administrators; NE Access enables its users to control access to applications and data through a partner portal; and ID Proxy enables its users to record and manage employee data.SecZetta is partnered with Courion, Cyber-Ark, and RSA.SecZetta was founded by David Pignolet in November 2006. It is based in Newport, Rhode Island. | $20.5M / Series B / Sep 30, 2021 | |
|
|
Mine provides a smart data assistant that enables people to discover and control their personal data online.With a simple and friendly app, and in less than 30 seconds, users can discover all the companies that hold sensitive data such as personal, financial, identity, health, and more. It helps discover, understand, and effectively manage whatthe internet knows about users, enabling people to reduce their unnecessary online exposure to minimize potential risks. | $9.5M / Series A / Oct 21, 2020 | |
|
|
Solebit provides the fastest, most accurate and cost-effective approach for the identification and prevention of zero-day malware and unknown threats. SoleGATE is the disruptive cyber protection software platform by Solebit, challenging the norms of currently available technologies that rely on slow, costly and mostly outdated, ineffective methodsof sandboxing, signatures and behavioral inspection.The solution is powered by DvC™ (data vs. code), a patented, real-time, signature-less engine. DvC assumes that there is no legitimate reason for executable code to be present in any data file. As such, it does not rely on heuristics or behaviors (which are core limitations of competing technologies), and definitively identifies and terminates any instance of malicious code such as hidden CPU instructions, encrypted and polymorphic payloads, shellcodes and other commands typically buried in data file. DvC also accurately identifies an blocks malicious active content using advanced flow analysis, de-obfuscation techniques and deep content evaluation, to reveal threat intent within any inbound data file covering machine, operating system and application levels, thereby rendering such sandbox evading attacks harmless to the enterprise.Solebit was founded in 2014 by a team of world-class cybersecurity experts, all graduates of the elite technology units in the Israel Defense Forces with years of experience in offensive and defensive security. It counts a variety of leading global financial organizations, tech, defense contractors, security vendors, cloud and telecom service providers as active customers. For more information, please visit solebit.io | $11M / Series A / Mar 14, 2018 | |
|
|
Tuition.io provides an employee benefit that enables employers to contribute directly to employees’ student loan debt. In addition, Tuition.io provides a web platform that helps employees manage and optimize their student debt through objective Financial Wellness education. | $7M / Series B / Sep 21, 2017 | |
|
|
Tuition.io provides an employee benefit that enables employers to contribute directly to employees’ student loan debt. In addition, Tuition.io provides a web platform that helps employees manage and optimize their student debt through objective Financial Wellness education. | $5M / Series A / Nov 18, 2015 | |
|
|
MC10, Inc. extends human capabilities through virtually invisible and conformal electronics. They reshape rigid, conventional electronics into thin, flexible devices that can stretch, bend and twist seamlessly with their bodies and the natural world. It combines breakthrough technology with innovative engineering to develop products that advancethe quality of life. The company's end-to-end system designed for In-Home and In-Clinic Study Execution. Its proprietary BioStamp system wearable health tech creates comfortable, discreet sensors that can be applied anywhere on the body for targeted data collection. With location-specific sensing capabilities, BioStamp sensors are able to retrieve real-world data about muscle activation and movement. | $10M / Series C / Dec 17, 2012 | |
|
|
MC10, Inc. extends human capabilities through virtually invisible and conformal electronics. They reshape rigid, conventional electronics into thin, flexible devices that can stretch, bend and twist seamlessly with their bodies and the natural world. It combines breakthrough technology with innovative engineering to develop products that advancethe quality of life. The company's end-to-end system designed for In-Home and In-Clinic Study Execution. Its proprietary BioStamp system wearable health tech creates comfortable, discreet sensors that can be applied anywhere on the body for targeted data collection. With location-specific sensing capabilities, BioStamp sensors are able to retrieve real-world data about muscle activation and movement. | $12.5M / Series B / Jun 28, 2011 | |
|
|
MC10, Inc. extends human capabilities through virtually invisible and conformal electronics. They reshape rigid, conventional electronics into thin, flexible devices that can stretch, bend and twist seamlessly with their bodies and the natural world. It combines breakthrough technology with innovative engineering to develop products that advancethe quality of life. The company's end-to-end system designed for In-Home and In-Clinic Study Execution. Its proprietary BioStamp system wearable health tech creates comfortable, discreet sensors that can be applied anywhere on the body for targeted data collection. With location-specific sensing capabilities, BioStamp sensors are able to retrieve real-world data about muscle activation and movement. | $6.2M / Series A |
Co-Investors
About MassMutual Ventures
MMV is a multi-stage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.MMV’s sole limited partner is MassMutual, a Fortune 500 financial services company withassets under management of $616 billion (Dec 2020).
MassMutual Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Charles Svirk
Principal
|
|||
|
Doug Russell
Managing Director and Head of MassMutual Ventures
|
|||
|
Eric Emmons
Managing Director
|
|||
|
Jason Allen
Lead Portfolio Manager Impact Investments
|
|||
|
Mark Goodman
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Mark Goodman invest in?
Mark Goodman invests primarily in Information Technology, Software and Cyber Security startups, most often at Series A and Series B stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Mark Goodman last invest?
The most recent investment recorded for Mark Goodman closed in Jan 2025. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!